With the acquisition, FTD’s sites in Luxembourg, Malta and India and its approximately 80 employee workforce will be folded into Siemens Healthineers business.
FTD produces a range of CE Mark approved infectious disease detection tests and syndromic panels, and will continue to operate under the brand name Fast Track Diagnostics, Siemens said.
“The closing of this deal enables both Siemens Healthineers and FTD—now joined as one—to more effectively address the evolving needs of the molecular diagnostics marketplace. It is an exciting time for us at Siemens Healthineers as we welcome the FTD community into our own,” Siemens molecular diagnostics head Fernando Beils said in a press release.
Terms of the deal were not disclosed by Siemens.
Last month, Siemens said it launched the Cardio dashboard application in its Siemens Healthineers cloud-based network of applications.